Remifentanil
- Generic Name
- Remifentanil
- Brand Names
- Ultiva
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28N2O5
- CAS Number
- 132875-61-7
- Unique Ingredient Identifier
- P10582JYYK
- Background
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
- Indication
For use during the induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
Concepts for Analgosedation During Placement of Regional Anaesthesia Before Operations.
- Conditions
- Interventions
- First Posted Date
- 2019-07-19
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Medical University of Graz
- Target Recruit Count
- 50
- Registration Number
- NCT04026074
- Locations
- 🇦🇹
Medical University Hospital LKH Graz, Graz, Austria
The PATHFINDER Study: A Feasibility Trial
- Conditions
- Interventions
- First Posted Date
- 2019-07-11
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT04016740
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Remifentanil Tapering and Post-adenotonsillectomy Pain in Children
- Conditions
- Interventions
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- University Hospital, Akershus
- Target Recruit Count
- 6
- Registration Number
- NCT03994146
- Locations
- 🇳🇴
Akershsus Universitetssykehus, Lørenskog, Akershus, Norway
🇳🇴Lovisenberg Diakonale Sykehus, Oslo, Norway
Sedation Strategies for Diagnostic Bronchoscopy 2
- Conditions
- Interventions
- First Posted Date
- 2019-06-12
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03983889
- Locations
- 🇨🇳
Faculty of Anesthesiology, Changhai Hospital, Shanghai, Shanghai, China
Sedation Strategies for Therapeutic Bronchoscopy 2
- Conditions
- Interventions
- First Posted Date
- 2019-06-12
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT03983915
- Locations
- 🇨🇳
Faculty of Anesthesiology, Changhai Hospital, Shanghai, Shanghai, China
Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Joshua A. Lile, Ph.D.
- Target Recruit Count
- 31
- Registration Number
- NCT03958474
- Locations
- 🇺🇸
Laboratory of Human Behavioral Pharmacology, Lexington, Kentucky, United States
Synchronous Effect of Anesthetics on fMRI, EEG and Clinical Responses
- First Posted Date
- 2019-04-26
- Last Posted Date
- 2022-09-30
- Lead Sponsor
- Parc de Salut Mar
- Target Recruit Count
- 30
- Registration Number
- NCT03928366
- Locations
- 🇪🇸
Hospital del Mar, Barcelona, Spain
Conscious Sedation for Outpatient Colonoscopy
- Conditions
- Interventions
- First Posted Date
- 2019-04-24
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Menoufia University
- Target Recruit Count
- 80
- Registration Number
- NCT03925779
- Locations
- 🇪🇬
Faculty of Medicine, Cairo, Shebin El-kom, Egypt
Effect of Dexmedetomidine on Nol-Index Guided Remifentanil Analgesia
- Conditions
- Interventions
- First Posted Date
- 2019-04-11
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- Erasme University Hospital
- Target Recruit Count
- 58
- Registration Number
- NCT03912740
- Locations
- 🇧🇪
Erasme University Hospital, Bruxelles, Belgium
Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery
- Conditions
- Interventions
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Francisco Andres de la Gala
- Target Recruit Count
- 156
- Registration Number
- NCT03905837
- Locations
- 🇪🇸
Hospital Gregorio Maranon, Madrid, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.